Eagle Pharmaceuticals Reports Second Quarter 2020 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals Reports Second Quarter 2020 Results

Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 34c, Revenues Miss

August 10, 2020 6:53 AM EDT

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q2 EPS of $0.57, $0.34 better than the analyst estimate of $0.23. Revenue for the quarter came in at $41.9 million versus the consensus estimate of $42.28 million.

We had an excellent start to the first half of the year, advancing our exciting pipeline of oncology and critical care products. Our ANDA and orphan drug exclusivity legal... More